BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
23 juin 2022 06h00 HE
|
BioNTech SE
Breaking of Ground for BioNTech’s initial African modular mRNA manufacturing facility in Kigali, Rwanda; delivery of first container modules planned for end of 2022On invitation by H.E. President Paul...
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
22 juin 2022 20h01 HE
|
Novartis Pharma AG
Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five yearsCommitment includes USD...
New Study Identifies Potential Immunotherapy Target for Malaria
09 mai 2022 10h00 HE
|
Experimental Biology and Medicine
WASHINGTON, May 09, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 8, April, 2022) identifies a new target for malaria treatment. The...
Insights on the Malaria Diagnostics Global Market to 2026 - by Technology, End-use and Region
25 mars 2022 08h58 HE
|
Research and Markets
Dublin, March 25, 2022 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Insights on the Hepatitis Diagnostic Tests Global Market to 2027 - Focus on Blood Tests, Imaging Tests and Liver Biopsies
02 mars 2022 07h23 HE
|
Research and Markets
Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Hydroxychloroquine Market Projected to Reach Over USD 2,598.6 Million by 2028 - Vantage Market Research
16 févr. 2022 07h39 HE
|
Vantage Market Research
WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Hydroxychloroquine Market size is expected to reach over USD 2,598.6 Million by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7%...
Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria
13 janv. 2022 09h05 HE
|
Vir Biotechnology, Inc.
– New commitment from the Bill & Melinda Gates Foundation supports the development of Vir’s novel “vaccinal antibody” technology as another important step in the fight to address global...
Global Dengue Testing Markets, 2026 - ELISA-based Tests Expected to Dominate, Asia-Pacific the Fastest Growing Market
22 déc. 2021 08h13 HE
|
Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Dengue Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)" report has been added to ResearchAndMarkets.com's offering. The...
Kainomyx Announces New Funding to Advance Programs Focused on Malaria and Other Parasitic Diseases
26 oct. 2021 15h41 HE
|
Kainomyx Inc.
PALO ALTO, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Kainomyx, Inc., founded in September 2019 and financed with $7.5M in May 2020, announced a new round of funding of $7.97M to advance its programs...
Gemeinsames Kommuniqué: BioNTech evaluiert Optionen zur Herstellung von mRNA-Impfstoffen in Ruanda und Senegal zur Unterstützung einer langfristigen Impfstoffversorgung in Afrika
27 août 2021 07h15 HE
|
BioNTech SE
BERLIN, DEUTSCHLAND, 27. August, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, den Aufbau nachhaltiger Produktionsmöglichkeiten für...